News

Under the terms of the agreement, DSM will supply naproxcinod active pharmaceutical ingredient (API) for commercial purposes from its fine chemicals production site in Linz, Austria. This follows

Study 205 is a double-blind, placebo-controlled, multi-center US and European Phase IIb trial in about 280 gastroesophageal reflux disease (GERD) patients who are partial responders to proton pump

In this position, Mr Titus will use his significant biotechnology industry experience to lead finance activities and investor relations for the company as well as oversee human resources,

The opioid-induced bowel dysfunction (OBD) pivotal assessment of lubiprostone (OPAL) program is designed to evaluate the effect of lubiprostone as a treatment for chronic pain patients suffering from

According to the company, the SafeSept transseptal guidewire is a novel guidewire designed to easily perforate the interatrial septum, immediately become atraumatic in the left atrium, enable fluoroscopic

The DSM Solutech business, which primarily consists of two production facilities in the Netherlands, contributed approximately E3 million to DSM’s total net sales in 2007. Lydall has been

The study, which was designed to evaluate the efficacy of five doses of GW642444 (‘444) administered once-daily for four weeks, showed dose dependent improvements in lung function. All

Under the terms of the agreement, Bayer Schering Pharma has agreed to pay ProStrakan unspecified upfront and milestone payments, subject to the achievement of certain approvals and sales

In this Phase I study, single and multiple escalating doses were administered to healthy volunteers. The data obtained show that Prodarsan is safe and well tolerated when used